ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 764135 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 764135; 2) Community: the network communities that were significantly associated with the response to NSC 764135; 3) Molecule: the relationships between components within communities and NSC 764135; 4) MDR: the compounds that were significantly associated with the NSC 764135.

NSC Compound Enrichment Correlation
NSC 678404 Null 0.0163859626459254 -0.17442413
NSC 702134 Null 0.0163859626459254 -0.1531315
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0163859626459254 -0.073553215
NSC 756833 Null 0.0163859626459254 0.39030462
NSC 123139 L-Cysteine, S-[(4-methylphenyl)diphenylmethyl]- (9CI) 0.0174563696971638 -0.09566563
NSC 154572 Null 0.0174563696971638 -0.24861646
NSC 175630 Toyocamycin, 6-amino- 0.0174563696971638 -0.22746498
NSC 237677 Null 0.0174563696971638 -0.14855671
NSC 240419 Benzoic acid, 2-[[4-[bis(2-bromopropyl)amino]-2-methylphenyl]azo]- 0.0174563696971638 0.061502821
NSC 365356 TETRACENOMYCIN C, AMINO-BUTYRYL- 0.0174563696971638 -0.026703269
Total:41  Current:13    [First] [Prev] [Next] [Last]